Everolimus-eluting stent for prevention of restenosis

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1441, 2004-01, pp. : 8-8

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Estradiol-eluting stent promising for prevention of restenosis

By  

Inpharma, Vol. 1, Iss. 1431, 2004-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Everolimus-eluting stent superior: the SPIRIT III trial

By  

Inpharma, Vol. 1, Iss. 1585, 2007-01 ,pp. : 9-10

Adis International

Access to resources Recommend Favorite

Sirolimus-eluting stent superior for coronary artery restenosis prevention

By  

Inpharma, Vol. 1, Iss. 1389, 2003-01 ,pp. : 13-14

Adis International

Access to resources Recommend Favorite

Everolimus-eluting stent edges ahead?

By  

Inpharma, Vol. 1, Iss. 1616, 2007-01 ,pp. : 13-14

Adis International

Access to resources Recommend Favorite

A polymer-free, sirolimus-eluting stent is as effective as a standard, polymer-based, paclitaxel-eluting stent in the prevention of coronary artery restenosis

By  

Inpharma, Vol. 1, Iss. 1530, 2006-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite